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the Invasive Evaluation of
Coronary Physiology?*
William F. Fearon, MD, Jennifer A. Tremmel, MD, MST here has been growing interest in and use ofwire-based methods for measuring variousindexes of coronary physiology to provide
information beyond the coronary angiogram re-
garding the functional signiﬁcance of coronary artery
disease. In particular, fractional ﬂow reserve (FFR)
has become the standard method for identifying
physiologically signiﬁcant epicardial coronary dis-
ease. Recently, Echavarria-Pinto et al. (1) and Lee
et al. (2) showed how measuring microvascular resis-
tance, in particular, the index of microcirculatory
resistance (IMR), can assess the contribution of
coronary microvascular dysfunction to ischemic heart
disease. In this issue of JACC: Cardiovascular
Interventions, there are 2 more reports regarding
potential methods for further optimizing our invasive
assessment of coronary physiology (3,4).SEE PAGES 1670 AND 1681In the ﬁrst paper by Echavarria-Pinto et al. (3), the
authors propose that by incorporating information
from the resting distal coronary pressure to aortic
pressure ratio (Pd/Pa) to traditional FFR measured
duringmaximal hyperemia, onemight be able to better
characterize the functional signiﬁcance of an inter-
mediate coronary stenosis. In 363 patients (467 ste-
noses) from 2 medical centers, they measured resting
and hyperemic pressure gradients and coronary ﬂow
with either a Doppler-tipped wire or by using a*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
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Volcano Corporation, and Boston Scientiﬁc.thermodilution technique. They found that resting Pd/
Pa correlated with FFR in roughly 80% of cases, similar
to what has been found in previous reports (5).
They then focused on thew20% of discordant cases
with either high resting Pd/Pa and abnormal FFR or low
resting Pd/Pa and normal FFR by examining the dif-
ferences in patient characteristics, coronary ﬂow,
coronary ﬂow reserve (CFR), and microvascular resis-
tance. Patients with high resting Pd/Pa and abnormal
FFR tended to be younger, more often male, less often
hypertensive, with fewer previous myocardial in-
farctions, and a tighter stenosis more often involving
the left anterior descending artery and perfusing
myocardium with a lower minimal myocardial resis-
tance. Importantly, the CFR in this group was the same
as it was across concordant stenoseswith a high resting
Pd/Pa and normal FFR, whereas the other discordant
group of patients, those with a low resting Pd/Pa and
normal FFR, had lower CFR values.
These ﬁndings demonstrate that the discordant
cases with low FFR across stenoses with higher resting
Pd/Pa values are not due to supranormal CFR, as has
been argued by some, but a reﬂection of a functionally
signiﬁcant stenosis being uncovered by administra-
tion of hyperemia in a vessel supplying a relatively
large amount of viable myocardium. Moreover, the
discordant cases with the low resting Pd/Pa and normal
FFR result more often in vessels subtending smaller
amounts of viable myocardium or territories with
greater degrees of microvascular dysfunction. These
are epicardial lesions with less functional signiﬁcance
in which epicardial revascularization will not signiﬁ-
cantly improve myocardial perfusion.
These ﬁndings beg the question “why is the resting
Pd/Pa insufﬁcient as a measure of epicardial stenosis?”
The ﬁrst and most obvious explanation is that estab-
lishing a true “resting” gradient across a given stenosis
or in a particular patient is extremely challenging, as
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1693ﬂow is constantly changing in response to varia-
tions in hemodynamics and myocardial demand.
The second reason has to do with the relationship
between FFR and myocardial mass. One would expect
a larger hyperemic gradient and greater difference
between FFR and resting Pd/Pa in a stenosed vessel
subtending a large amount of viable myocardium.
This would explain why discordance with a higher
resting Pd/Pa and abnormal FFR was seen more
commonly in the left anterior descending arteries of
younger men.
Finally, the geometry of a stenosis and its relative
contribution to the friction and separation forces will
affect the change in pressure as ﬂow increases based
on the following equation: DP ¼ fQ þ sQ2, where DP
represents the change in pressure across the stenosis,
f the frictional coefﬁcient, s the separation coefﬁ-
cient, and Q the ﬂow across the stenosis (6). A long
moderate lesion across which the frictional coefﬁ-
cient predominates may have a relatively lower
resting Pd/Pa with a modest change in the pressure
gradient as ﬂow increases. However, a focal more
severe lesion across which the separation coefﬁcient
predominates may have a high resting Pd/Pa with a
much more dramatic increase in the gradient as ﬂow
increases (6). Only with maximal hyperemia can the
true effect of the stenosis be uncovered.
The authors argue that because resting Pd/Pa
correlated with CFR more closely than did FFR,
resting Pd/Pa provides valuable information above
and beyond FFR. In the catheterization laboratory,
we are most often concerned about whether an in-
termediate stenosis is responsible for myocardial
ischemia and therefore warrants revascularization.
FFR characterizes the contribution of the epicardial
disease to myocardial ischemia independent of
the microcirculation, whereas CFR interrogates the
contribution of both the epicardial disease and
microvascular dysfunction (7). For this reason, the
closer correlation between resting Pd/Pa and CFR
actually confounds the ability of resting Pd/Pa to
provide information regarding the speciﬁc contribu-
tion of the epicardial vessel to the development of
myocardial ischemia. If further information regarding
the microcirculation is desired, IMR, a measure
of microvascular dysfunction independent of the
epicardial stenosis, can be obtained simultaneously
with FFR and the same pressure wire (2).
They also argue that in discordant cases with a low
resting Pd/Pa and normal FFR, because CFR tended to
be lower, these patients may be at higher risk of
future events. However, numerous previous studies
have demonstrated excellent clinical outcome in pa-
tients with a nonischemic FFR (8–10). The authorscorrectly acknowledge that the inferences they make
about the prognostic value of invasively derived CFR
are speculative given the well-documented clinical
beneﬁt of FFR-guided PCI and that the prognostic
value of CFR comes primarily from noninvasively
derived CFR studies in larger and more heteroge-
neous populations of patients.
In the second paper, van de Hoef et al. (4) evaluate
a new index for identifying myocardial ischemia
referred to as coronary ﬂow capacitance (CFC) (4).
CFC is deﬁned as CFR divided by hyperemic coronary
ﬂow and was ﬁrst described by Johnson and Gould
(11) using positron emission tomography. Because
CFR is deﬁned as hyperemic coronary ﬂow divided by
resting ﬂow, CFC is a method for normalizing the
CFR to the maximal achievable ﬂow and mitigating
the effect of resting ﬂow on the equation. Because
FFR speciﬁcally evaluates the contribution of an
epicardial stenosis to the development of myocardial
ischemia and because ischemia from microvascular
dysfunction can also contribute to adverse outcomes,
the investigators aimed to test whether CFC can
improve on the discrimination of adverse outcomes,
particularly when compared with CFR alone.
The investigators retrospectively calculated CFC
from their database of 228 patients and 299 vessels (the
same cohort included in the paper by Echavarria-Pinto
et al. [3]) in whom they performed both invasive cor-
onary pressure and Doppler ﬂow velocity measure-
ments and have a mean follow-up of 11.9 years. In 159
of these patients, revascularizationwas deferred based
on undisclosed criteria, and follow-up was obtained in
154 patients who serve as the basis for this report. One
stenosis per patient was arbitrarily chosen for follow-
up. They found that CFC was an independent predic-
tor of major adverse cardiac events (MACE) with more
robust discrimination compared with CFR alone.
The potential advantage of CFC is that it inter-
rogates the entire coronary circulation for the presence
of myocardial ischemia and weighs hyperemic ﬂow
more than resting ﬂow. However, a major limitation of
this second paper is the fact that the investigators did
not report the relationship between CFC and the rates
of the individual components of MACE (death,
myocardial infarction, or revascularization). This is
particularly relevant because the investigators previ-
ously found that CFR was a better predictor of overall
MACE compared with FFR, but not death and
myocardial infarction (12). In this previous report, the
higher MACE rate in the patients with normal FFR and
abnormal CFR was driven entirely by a dramatically
higher revascularization rate during the ﬁrst year of
follow-up. At 5-year follow-up, the rate of the hard
endpoints of death and myocardial infarction was
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1694actually lower in the group with normal FFR and low
CFR at 14%, whereas it was 20% in the group with
abnormal FFR and normal CFR, suggesting that FFR
may have been a better predictor of hard events
compared with CFR in this cohort.
Some other limitations acknowledged by the
authors include the low dose of intracoronary aden-
osine used (20 to 40 mg), which likely did not result in
maximal hyperemia in all cases, the lack of prospec-
tive follow-up and independent adjudication of
events, the lack of pre-speciﬁed and clearly deﬁned
cutoff values for CFC, and the technical challenges
associated with making Doppler ﬂow measurements,
which may limit the clinical applicability of this
technique. Finally, the authors measured Doppler
wire–derived microvascular resistance (HMR), which
one would expect to be speciﬁc for microvascular
dysfunction, but unfortunately they do not report
its relationship to CFR, CFC, or MACE.
Currently, in the catheterization laboratory, if
we are interested in the contribution of epicardial
disease (either focal or diffuse) to the development
of myocardial ischemia, we can measure FFR. The
adverse implication of an abnormal FFR in a patient
treated with medication alone, as well as the good
prognosis associated with a normal FFR, has been
demonstrated in multiple prospective, multicenter,
randomized trials, registries, and large meta-analyses
(8–10,13). However, if we are concerned about the
speciﬁc contribution of microvascular dysfunction to
myocardial ischemia and adverse outcomes, we cansimultaneously measure microvascular resistance,
for example, IMR or HMR. Particularly in patients
with acute microvascular dysfunction, such as after
primary percutaneous coronary intervention for
ST-segment elevation myocardial infarction, IMR
has been shown to be an independent predictor of
long-term mortality, whereas CFR was not (14).
One advantage of simultaneously measuring FFR
and IMR is that one can evaluate the entire coronary
circulation, as aimed for with CFC, while also gaining
an understanding of the independent contributions
from the epicardial stenosis and the microcirculation.
Another advantage is that both measures are made
during maximal hyperemia, so the variability of
resting ﬂow is not an issue. If one is interested in the
contribution of both the epicardial component and
the microvasculature combined, CFR has been the
traditional standard method; however, the current
study suggests that CFC outperforms CFR. Whether
CFC adds to this paradigm and/or replaces CFR will
need to be tested prospectively in an outcome study.
Both Echavarria-Pinto et al. (3) and van de Hoef
et al. (12), should be congratulated for their attempts
to further reﬁne our methods for the invasive
assessment of coronary physiology. Future study will
perhaps clarify the roles of their proposed techniques.
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